• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病作为重症肌无力的一个潜在危险因素:一项病例对照研究。

Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study.

作者信息

Liu Yu-Dong, Tang Fang, Li Xiao-Li, Liu Ya-Fei, Zhang Peng, Yang Chun-Lin, Du Tong, Li Heng, Wang Cong-Cong, Liu Ying, Yang Bing, Duan Rui-Sheng

机构信息

Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.

Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.

出版信息

Front Neurol. 2023 Apr 17;14:1125842. doi: 10.3389/fneur.2023.1125842. eCollection 2023.

DOI:10.3389/fneur.2023.1125842
PMID:37139075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10149973/
Abstract

BACKGROUND

A certain number of myasthenia gravis (MG) patients clinically had type 2 diabetes mellitus (T2DM) prior to MG onset, which suggests that the onset of MG may correlate with the history of T2DM. This study aimed to examine the correlation between MG and T2DM.

METHODS

In a single-center, retrospective, 1:5 matched case-control study, all 118 hospitalized patients with a diagnosis of MG from 8 August 2014 to 22 January 2019 were enrolled. In total, four datasets with different sources of the control group were retrieved from the electronic medical records (EMRs). Data were collected at the individual level. A conditional logistic regression analysis was used to test the risk of MG associated with T2DM.

FINDINGS

The risk of MG was significantly associated with T2DM, and there were notable differences by sex and age. Whether compared to the general population, general hospitalized patients without autoimmune diseases (AIDs), or patients with other AIDs except MG, women aged over 50 years with T2DM had an increased risk of MG. The mean onset age of diabetic MG patients was more than that of the non-diabetic MG patients.

INTERPRETATION

This study demonstrates that T2DM is strongly associated with the subsequent risk of MG and varies significantly by sex and age. It reveals that diabetic MG may be a unique subtype that is different from the conventional MG subgroup classification. More clinical and immunological features of diabetic MG patients need to be explored in further studies.

摘要

背景

一定数量的重症肌无力(MG)患者在MG发病前临床上已患有2型糖尿病(T2DM),这表明MG的发病可能与T2DM病史相关。本研究旨在探讨MG与T2DM之间的相关性。

方法

在一项单中心、回顾性、1:5匹配的病例对照研究中,纳入了2014年8月8日至2019年1月22日期间所有118例住院诊断为MG的患者。总共从电子病历(EMR)中检索了四个不同来源的对照组数据集。数据在个体层面收集。采用条件逻辑回归分析来检验与T2DM相关的MG风险。

结果

MG风险与T2DM显著相关,且在性别和年龄方面存在显著差异。与普通人群、无自身免疫性疾病(AIDs)的普通住院患者或除MG外的其他AIDs患者相比,50岁以上患有T2DM的女性患MG的风险增加。糖尿病性MG患者的平均发病年龄高于非糖尿病性MG患者。

解读

本研究表明T2DM与随后发生MG的风险密切相关,且在性别和年龄上有显著差异。它揭示了糖尿病性MG可能是一种独特的亚型,不同于传统的MG亚组分类。糖尿病性MG患者更多的临床和免疫学特征需要在进一步研究中探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/e23f5f8cbf9f/fneur-14-1125842-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/340945906cea/fneur-14-1125842-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/5d88f2e807ca/fneur-14-1125842-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/e23f5f8cbf9f/fneur-14-1125842-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/340945906cea/fneur-14-1125842-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/5d88f2e807ca/fneur-14-1125842-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2c/10149973/e23f5f8cbf9f/fneur-14-1125842-g0003.jpg

相似文献

1
Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study.2型糖尿病作为重症肌无力的一个潜在危险因素:一项病例对照研究。
Front Neurol. 2023 Apr 17;14:1125842. doi: 10.3389/fneur.2023.1125842. eCollection 2023.
2
Association Analysis Between Different Diabetic Family History and Gender with Diagnosed Age of Type 2 Diabetes Mellitus: A Cross-Sectional Study in Tianjin, China.中国天津一项横断面研究:2 型糖尿病发病年龄与不同糖尿病家族史及性别关联性分析。
Inquiry. 2022 Jan-Dec;59:469580221086364. doi: 10.1177/00469580221086364.
3
Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.难治性重症肌无力——临床特征、合并症及对利妥昔单抗的反应
Ger Med Sci. 2016 Oct 13;14:Doc12. doi: 10.3205/000239. eCollection 2016.
4
Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.糖尿病通过调节适应性和固有免疫加剧实验性自身免疫性重症肌无力。
J Neuroinflammation. 2021 Oct 26;18(1):244. doi: 10.1186/s12974-021-02298-6.
5
Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.皮肤自发荧光与 2 型糖尿病患者并发症的复杂性:一项横断面研究。
BMC Endocr Disord. 2021 Apr 1;21(1):58. doi: 10.1186/s12902-021-00725-6.
6
Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes.糖尿病视网膜病变是否受糖尿病类型影响?一项使用成人隐匿性自身免疫性糖尿病、1 型糖尿病和 2 型糖尿病患者电子病历数据的回顾性研究。
Acta Diabetol. 2021 Nov;58(11):1503-1511. doi: 10.1007/s00592-021-01748-0. Epub 2021 Jun 13.
7
Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.比较新诊断全身型重症肌无力和难治性全身型重症肌无力的利妥昔单抗治疗效果。
JAMA Neurol. 2020 Aug 1;77(8):974-981. doi: 10.1001/jamaneurol.2020.0851.
8
Clinical features of and risk factors for normoalbuminuric diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: a retrospective cross-sectional study.住院 2 型糖尿病患者正常白蛋白尿期糖尿病肾病的临床特征及危险因素:一项回顾性横断面研究。
BMC Endocr Disord. 2021 May 22;21(1):104. doi: 10.1186/s12902-021-00769-8.
9
Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.成人眼肌型重症肌无力转化:中国单中心回顾性分析。
Eur Neurol. 2020;83(2):182-188. doi: 10.1159/000507853. Epub 2020 Jun 11.
10
Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.早发型 2 型糖尿病的临床特征及微血管并发症危险因素。
Curr Med Sci. 2019 Oct;39(5):754-758. doi: 10.1007/s11596-019-2102-7. Epub 2019 Oct 14.

引用本文的文献

1
Risk of Diabetes Mellitus in the Myasthenia Gravis: A Systematic Review and Meta-Analysis.重症肌无力患者患糖尿病的风险:一项系统评价和荟萃分析。
J Clin Med. 2025 Jun 13;14(12):4221. doi: 10.3390/jcm14124221.
2
Phenotypic and functional dysregulations of CD8 + T Cells in myasthenia gravis.重症肌无力中CD8 + T细胞的表型和功能失调
Clin Exp Med. 2025 Mar 25;25(1):96. doi: 10.1007/s10238-025-01603-4.
3
Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis.重症肌无力患者的糖尿病:一项系统评价和荟萃分析。

本文引用的文献

1
Diabetes mellitus aggravates humoral immune response in myasthenia gravis by promoting differentiation and activation of circulating Tfh cells.糖尿病通过促进循环滤泡辅助性T细胞的分化和激活加重重症肌无力的体液免疫反应。
Clin Immunol. 2022 Dec;245:109141. doi: 10.1016/j.clim.2022.109141. Epub 2022 Oct 18.
2
Unraveling the Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Myasthenia Gravis.解析晚期糖基化终末产物受体(RAGE)及其配体在重症肌无力中的作用
ACS Chem Neurosci. 2020 Mar 4;11(5):663-673. doi: 10.1021/acschemneuro.9b00678. Epub 2020 Feb 13.
3
HLA in myasthenia gravis: From superficial correlation to underlying mechanism.
Endocrine. 2025 Apr;88(1):24-35. doi: 10.1007/s12020-024-04143-1. Epub 2024 Dec 27.
4
Causal relationship between the immune phenotype of monocytes and myasthenia gravis: A Mendelian randomization study.单核细胞免疫表型与重症肌无力之间的因果关系:一项孟德尔随机化研究。
Heliyon. 2024 Feb 20;10(5):e26741. doi: 10.1016/j.heliyon.2024.e26741. eCollection 2024 Mar 15.
重症肌无力中的 HLA:从表面相关性到潜在机制。
Autoimmun Rev. 2019 Sep;18(9):102349. doi: 10.1016/j.autrev.2019.102349. Epub 2019 Jul 16.
4
Clinical differences of early and late-onset myasthenia gravis in 985 patients.985例早发型和晚发型重症肌无力的临床差异
Neurol Res. 2019 Jan;41(1):45-51. doi: 10.1080/01616412.2018.1525121. Epub 2018 Oct 12.
5
Microfluidic devices for disease modeling in muscle tissue.用于肌肉组织疾病建模的微流控装置。
Biomaterials. 2019 Apr;198:250-258. doi: 10.1016/j.biomaterials.2018.08.059. Epub 2018 Aug 30.
6
Damage-Associated Molecular Patterns in Inflammatory Diseases.炎症性疾病中的损伤相关分子模式
Immune Netw. 2018 Aug 13;18(4):e27. doi: 10.4110/in.2018.18.e27. eCollection 2018 Aug.
7
Nature and Action of Antibodies in Myasthenia Gravis.重症肌无力中抗体的性质与作用
Neurol Clin. 2018 May;36(2):275-291. doi: 10.1016/j.ncl.2018.01.001.
8
Diagnosis of Myasthenia Gravis.重症肌无力的诊断
Neurol Clin. 2018 May;36(2):261-274. doi: 10.1016/j.ncl.2018.01.010.
9
[Glucose and lipid metabolic disorders in myasthenia gravis patients and its mechanisms].[重症肌无力患者的糖脂代谢紊乱及其机制]
Zhonghua Yi Xue Za Zhi. 2018 Feb 27;98(8):581-586. doi: 10.3760/cma.j.issn.0376-2491.2018.08.005.
10
Late-onset myasthenia gravis is predisposed to become generalized in the elderly.迟发性重症肌无力在老年人中易发展为全身性。
eNeurologicalSci. 2016 Feb 11;2:17-20. doi: 10.1016/j.ensci.2016.02.004. eCollection 2016 Mar.